Received 25 February 2013
aDepartment of Physics, Faculty of Sciences, Erciyes University, 38039 Kayseri, Turkey,bDepartment of Chemistry, Louisiana State University, Baton Rouge, LA 70803-1804, USA,cChemistry Department, Faculty of Science, Minia University, El-Minia, Egypt,dChemistry and Environmental Division, Manchester Metropolitan University, Manchester M1 5GD, England,eManedaliev Institute of Petrochemical Processes, National Academy of Sciences of Azerbaijan, Baku, Azerbaijan, and fPharmaceutical Chemistry Department, Faculty of Pharmacy, Al Azhar University, Egypt
Correspondence e-mail: email@example.com, firstname.lastname@example.org
The title compound, C26H25N3, crystallizes with four independent molecules, 1-4, in the asymmetric unit of the triclinic unit cell. The allyl substituents on the imidazole rings adopt similar conformations in all four molecules. The imadazole and the 4-and 5-substituted phenyl rings of two pairs of molecules in the asymmetric unit stack parallel to (110). In contrast, the dimethylaniline systems in these pairs of molecules are almost normal to one another, with dihedral angles of 85.84 (10) and 85.65 (10)° between the benzene rings of the two dimethylaniline fragments of molecules 1 and 2, and 3 and 4, respectively. The crystal structure features an extensive series of C-H interactions that link the molecules into undulating rows along the c axis. The crystal studied was a pseudo-merohedral twin with twin law [-100, 0-10, 111] and the BASF parameter refined to 0.513 (3).
For the synthesis and bioactivity of related heterocyclic molecules, see: El-Sawy et al. (2012); Issac et al. (2012); Mohamed, Abdelhamid et al. (2012); Soliman et al. (2012). For the synthesis of a similar imidazole derivative, see: Mohamed, Akkurt et al. (2012). For bond-length data, see: Allen et al. (1987).
Data collection: APEX2 (Bruker, 2005); cell refinement: SAINT (Bruker, 2005); data reduction: SAINT (Bruker, 2005); program(s) used to solve structure: SHELXS97 (Sheldrick, 2008); program(s) used to refine structure: SHELXL97 (Sheldrick, 2008); molecular graphics: ORTEP-3 for Windows (Farrugia, 2012); software used to prepare material for publication: WinGX (Farrugia, 2012) and PLATON (Spek, 2009).
Supplementary data and figures for this paper are available from the IUCr electronic archives (Reference: SJ5302 ).
Manchester Metropolitan University, Erciyes University and Louisiana State University are gratefully acknowledged for supporting this study.
Allen, F. H., Kennard, O., Watson, D. G., Brammer, L., Orpen, A. G. & Taylor, R. (1987). J. Chem. Soc. Perkin Trans. 2, pp. S1-19.
Bruker (2005). APEX2 and SAINT. Bruker AXS Inc., Madison, Wisconsin, USA.
El-Sawy, A. A., Mohamed, S. K., Eissa, A. M. F., Tantawy, A. H. & Issac, Y. A. (2012). J. Chem. Pharm. Res. 4, 2755-2762.
Farrugia, L. J. (2012). J. Appl. Cryst. 45, 849-854.
Issac, Y. A., Mohamed, S. K., Eissa, A. M. F., Tantawy, A. H. & El-Sawy, A. A. (2012). J. Chem. Pharm. Res. 4, 2744-2750.
Mohamed, S. K., Abdelhamid, A. A., Maharramov, A. M., Khalilov, A. N., Gurbanov, A. V. & Allahverdiyev, M. A. (2012). J. Chem. Pharm. Res. 4, 955-965.
Mohamed, S. K., Akkurt, M., Fronczek, F. R., Marzouk, A. A. E. & Abdelhamid, A. A. (2012). Acta Cryst. E68, o2979-o2980.
Sheldrick, G. M. (2004). SADABS. University of Göttingen, Germany.
Sheldrick, G. M. (2008). Acta Cryst. A64, 112-122.
Soliman, A. M., Mohamed, S. K., Elremaily, M. A. A. & Abdel-Ghany, H. (2012). Eur. J. Med. Chem. 47, 138-142.
Spek, A. L. (2009). Acta Cryst. D65, 148-155.